Canopy Growth Corporation shareholders authorize up to 1‑for‑15 reverse split
Directors retain discretion over the ratio for common and exchangeable shares, with no effective date set in the voting disclosure.
Adrian Kessler
Authority to consolidate as many as 15 existing shares into one passed on Friday as Canopy Growth Corporation TSEWEED NASDAQCGC secured shareholder approval for a possible reverse stock split. Directors can choose a ratio between 1-for-5 and 1-for-15, but the vote itself does not execute a consolidation.
The company's Oct. 23 SEC filing records approval of an amendment covering both common shares and exchangeable shares. The board has sole discretion over the exact whole-number ratio, which must apply to both classes.
Canopy is a Canadian cannabis company based in Smiths Falls, Ontario, with an international business serving medical patients and adult consumers. Its portfolio includes cannabis brands and vaporizers, alongside an unconsolidated, non-controlling interest in Canopy USA.
Canopy shares closed at US$0.68 on Nasdaq at 4:00 p.m. EDT on Oct. 23, according to the NASDAQCGC. The SEC accepted the voting report after that close, so the closing price preceded publication of the filing.
Directors Retain Control Of The Ratio
The resolution received 121,567,723 votes in favour and 28,460,796 against at the reconvened meeting. Another 4,809,378 votes abstained, according to the filing.
Approval gives directors flexibility over the size of any consolidation rather than establishing a single exchange ratio. The same resolution covers the two share classes, so directors cannot select a different consolidation ratio for each. The consolidation section of the report does not set an effective date or provide a post-consolidation share count.
The resolution's timing language also extends beyond the meeting itself. It permits implementation before Sept. 25, 2027, or the date twelve months after an adjourned or postponed meeting reconvenes, as applicable.
“Based on the votes set forth above, Canopy Growth’s shareholders approved the Share Consolidation Resolution,” the company said in the filing.
A consolidation combines existing shares into fewer units. The authorized range means five existing shares could become one at its lower end, or fifteen could become one at its upper end. It does not itself bring new cash into the company, and a higher nominal price following a consolidation would have to be distinguished from an increase in the value of the business.
The meeting had originally convened on Sept. 25 before being adjourned and reconvened on Oct. 23. The voting report records approximately 154.8 million common shares represented, against approximately 423.0 million entitled to vote as of the record date.
Tilray Provides A Capital Structure Comparison
Tilray Brands, Inc. TSETLRY NASDAQTLRY provides a cannabis-sector example of the separate authorization and implementation stages. Its Nov. 26, 2025 announcement selected a 1-for-10 reverse split after shareholders had approved a wider range in June.
Tilray said its outstanding common shares would fall from approximately 1.16 billion to 116 million. It expected split-adjusted trading to begin on Dec. 2, 2025, illustrating the additional implementation disclosure that follows shareholder authorization.
Tilray traded at C$3.94 in Toronto at 4:00 p.m. EDT on Oct. 23, according to its TSETLRY. That nominal share price alone provides no comparison of the two companies' valuations.
Canopy's operating disclosures remain separate from its capital structure vote.
Read more: Canopy Growth gains EU GMP certification for Smiths Falls softgels
Canopy's next scheduled financial checkpoint is Nov. 6, before markets open, when it will report results for the quarter ended Sept. 30. Those results will show the operating performance behind the shares directors have been authorized to consolidate.
